Literature DB >> 23207449

Impaired cornea wound healing in a tenascin C-deficient mouse model.

Takayoshi Sumioka1, Ai Kitano, Kathleen C Flanders, Yuka Okada, Osamu Yamanaka, Norihito Fujita, Hiroki Iwanishi, Winston W-Y Kao, Shizuya Saika.   

Abstract

We investigated the effects of loss of tenascin C on the healing of the stroma using incision-injured mice corneas. Tenascin C was upregulated in the stroma following incision injury to the cornea. Wild-type (WT) and tenascin C-null (knockout (KO)) mice on a C57BL/6 background were used. Cell culture experiments were also conducted to determine the effects of the lack of tenascin C on fibrogenic gene expression in ocular fibroblasts. Histology, immunohistochemistry and real-time reverse transcription PCR were employed to evaluate the healing process in the stroma. The difference in the incidence of wound closure was statistically analyzed in hematoxylin and eosin-stained samples between WT and KO mice in addition to qualitative observation. Healing of incision injury in corneal stroma was delayed, with less appearance of myofibroblasts, less invasion of macrophages and reduction in expression of collagen Iα1, fibronectin and transforming growth factor β1 (TGFβ1) in KO mice compared with WT mice. In vitro experiments showed that the loss of tenascin C counteracted TGFβ1 acceleration of mRNA expression of TGFβ1, and of collagen Iα1 and of myofibroblast conversion in ocular fibroblasts. These results indicate that tenascin C modulates wound healing-related fibrogenic gene expression in ocular fibroblasts and is required for primary healing of the corneal stroma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207449     DOI: 10.1038/labinvest.2012.157

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

Review 1.  Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.

Authors:  Lorena Zuliani-Alvarez; Kim S Midwood
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-05-01       Impact factor: 4.730

Review 2.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

3.  The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology.

Authors:  Sunil K Parapuram; William Hodge
Journal:  J Cell Commun Signal       Date:  2014-03-07       Impact factor: 5.782

4.  Wounded embryonic corneas exhibit nonfibrotic regeneration and complete innervation.

Authors:  James W Spurlin; Peter Y Lwigale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-24       Impact factor: 4.799

Review 5.  Tenascins in fibrotic disorders-from bench to bedside.

Authors:  M Kasprzycka; C Hammarström; G Haraldsen
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 6.  Progress in corneal wound healing.

Authors:  Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Prog Retin Eye Res       Date:  2015-07-18       Impact factor: 21.198

7.  Extra Cellular Matrix Remodeling: An Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration.

Authors:  Ashish Kumar; Neeraj Kumar; Zarna Pathak; Hemant Kumar
Journal:  Neurospine       Date:  2022-09-30

Review 8.  Extracellular matrix regulation of inflammation in the healthy and injured spinal cord.

Authors:  Andrew D Gaudet; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

9.  1,25-dihydroxyvitamin D3 inhibits corneal wound healing in an ex-vivo mouse model.

Authors:  Saadettin Sel; Stefanie Trau; Friedrich Paulsen; Thomas Kalinski; Gabriele I Stangl; Norbert Nass
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-21       Impact factor: 3.117

Review 10.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.